116 related articles for article (PubMed ID: 20593922)
1. Carcinogenic risk assessment: are there dose thresholds for carcinogens?
Fukushima S
Asian Pac J Cancer Prev; 2010; 11(1):19-21. PubMed ID: 20593922
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of hepatocarcinogenesis by combined administration of food-derived heterocyclic amines at low doses in the rat.
Hasegawa R; Kato T; Hirose M; Takahashi S; Shirai T; Ito N
Food Chem Toxicol; 1996; 34(11-12):1097-101. PubMed ID: 9119321
[TBL] [Abstract][Full Text] [Related]
3. Synergistic enhancement of hepatic foci development by combined treatment of rats with 10 heterocyclic amines at low doses.
Hasegawa R; Miyata E; Futakuchi M; Hagiwara A; Nagao M; Sugimura T; Ito N
Carcinogenesis; 1994 May; 15(5):1037-41. PubMed ID: 8200065
[TBL] [Abstract][Full Text] [Related]
4. Diethylnitrosamine exposure-responses for DNA ethylation, hepatocellular proliferation, and initiation of carcinogenesis in rat liver display non-linearities and thresholds.
Williams GM; Iatropoulos MJ; Jeffrey AM; Luo FQ; Wang CX; Pittman B
Arch Toxicol; 1999 Sep; 73(7):394-402. PubMed ID: 10550482
[TBL] [Abstract][Full Text] [Related]
5. Qualitative and quantitative approaches in the dose-response assessment of genotoxic carcinogens.
Fukushima S; Gi M; Kakehashi A; Wanibuchi H; Matsumoto M
Mutagenesis; 2016 May; 31(3):341-6. PubMed ID: 26152227
[TBL] [Abstract][Full Text] [Related]
6. Lack of potential of low dose N-nitrosodimethylamine to induce preneoplastic lesions, glutathione S-transferase placental form-positive foci, in rat liver.
Fukushima S; Wanibuchi H; Morimura K; Nakae D; Tsuda H; Imaida K; Shirai T; Tatematsu M; Tsukamoto T; Hirose M; Furukawa F
Cancer Lett; 2005 May; 222(1):11-5. PubMed ID: 15837536
[TBL] [Abstract][Full Text] [Related]
7. Lack of a dose-response relationship for carcinogenicity in the rat liver with low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline or N-nitrosodiethylamine.
Fukushima S; Wanibuchi H; Morimura K; Wei M; Nakae D; Konishi Y; Tsuda H; Uehara N; Imaida K; Shirai T; Tatematsu M; Tsukamoto T; Hirose M; Furukawa F; Wakabayashi K; Totsuka Y
Jpn J Cancer Res; 2002 Oct; 93(10):1076-82. PubMed ID: 12417036
[TBL] [Abstract][Full Text] [Related]
8. Lack of initiation activity in rat liver of low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.
Fukushima S; Wanibuchi H; Morimura K; Wei M; Nakae D; Konishi Y; Tsuda H; Takasuka N; Imaida K; Shirai T; Tatematsu M; Tsukamoto T; Hirose M; Furukawa F
Cancer Lett; 2003 Feb; 191(1):35-40. PubMed ID: 12609707
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic basis for nonlinearities and thresholds in rat liver carcinogenesis by the DNA-reactive carcinogens 2-acetylaminofluorene and diethylnitrosamine.
Williams GM; Iatropoulos MJ; Jeffrey AM
Toxicol Pathol; 2000; 28(3):388-95. PubMed ID: 10862555
[TBL] [Abstract][Full Text] [Related]
10. Dose dependence of phenobarbital promotion of preneoplastic hepatic lesions in F344 rats and B6C3F1 mice: effects on DNA synthesis and apoptosis.
Kolaja KL; Stevenson DE; Walborg EF; Klaunig JE
Carcinogenesis; 1996 May; 17(5):947-54. PubMed ID: 8640942
[TBL] [Abstract][Full Text] [Related]
11. Value of GST-P positive preneoplastic hepatic foci in dose-response studies of hepatocarcinogenesis: evidence for practical thresholds with both genotoxic and nongenotoxic carcinogens. A review of recent work.
Tsuda H; Fukushima S; Wanibuchi H; Morimura K; Nakae D; Imaida K; Tatematsu M; Hirose M; Wakabayashi K; Moore MA
Toxicol Pathol; 2003; 31(1):80-6. PubMed ID: 12597451
[TBL] [Abstract][Full Text] [Related]
12. Phenobarbital at low dose exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage, altering cell proliferation, apoptosis and gene expression.
Kinoshita A; Wanibuchi H; Morimura K; Wei M; Shen J; Imaoka S; Funae Y; Fukushima S
Carcinogenesis; 2003 Aug; 24(8):1389-99. PubMed ID: 12807726
[TBL] [Abstract][Full Text] [Related]
13. The carcinogenic effect of methapyrilene combined with nitrosodiethylamine given to rats in low doses.
Lijinsky W; Kovatch RM; Thomas BJ
Carcinogenesis; 1992 Jul; 13(7):1293-7. PubMed ID: 1638702
[TBL] [Abstract][Full Text] [Related]
14. Low dose DDT inhibition of hepatocarcinogenesis initiated by diethylnitrosamine in male rats: possible mechanisms.
Kushida M; Sukata T; Uwagawa S; Ozaki K; Kinoshita A; Wanibuchi H; Morimura K; Okuno Y; Fukushima S
Toxicol Appl Pharmacol; 2005 Nov; 208(3):285-94. PubMed ID: 15885732
[TBL] [Abstract][Full Text] [Related]
15. Detection of initiating potential of non-genotoxic carcinogens in a two-stage hepatocarcinogenesis study in rats.
Omura K; Uehara T; Morikawa Y; Hayashi H; Mitsumori K; Minami K; Kanki M; Yamada H; Ono A; Urushidani T
J Toxicol Sci; 2014; 39(5):785-94. PubMed ID: 25242409
[TBL] [Abstract][Full Text] [Related]
16. Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rats: dose-response studies.
Shirai T; Tamano S; Sano M; Masui T; Hasegawa R; Ito N
Princess Takamatsu Symp; 1995; 23():232-9. PubMed ID: 8844814
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of hepatocarcinogenesis by kojic acid in rat two-stage models after initiation with N-bis(2-hydroxypropyl)nitrosamine or N-diethylnitrosamine.
Takizawa T; Imai T; Onose J; Ueda M; Tamura T; Mitsumori K; Izumi K; Hirose M
Toxicol Sci; 2004 Sep; 81(1):43-9. PubMed ID: 15201437
[TBL] [Abstract][Full Text] [Related]
18. Existence of no-observed effect levels for 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline on hepatic preneoplastic lesion development in BN rats.
Wei M; Hori TA; Ichihara T; Wanibuchi H; Morimura K; Kang JS; Puatanachokchai R; Fukushima S
Cancer Lett; 2006 Jan; 231(2):304-8. PubMed ID: 16399231
[TBL] [Abstract][Full Text] [Related]
19. Medium-term rat liver bioassay for rapid detection of carcinogens and modifiers of hepatocarcinogenesis.
Ito N; Hasegawa R; Imaida K; Takahashi S; Shirai T
Drug Metab Rev; 1994; 26(1-2):431-42. PubMed ID: 8082578
[TBL] [Abstract][Full Text] [Related]
20. Enhancing effects of phenobarbital and 3-methylcholanthrene on GST-P-positive liver cell foci development in a new medium-term rat liver bioassay using D-galactosamine.
Kim HC; Lee YS; Nishikawa A
J Toxicol Environ Health; 1997 Apr; 50(5):519-28. PubMed ID: 9140468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
